Figure 3

Proteome profiling of cell stress proteins. Equal amounts of protein from control (N = 18) and RIPC patients (N = 18) were pooled and employed in the array. Only proteins with signal intensities ≥10% of the internal reference control protein spot (not shown) were quantified. Numbers in the table represent the densitometric intensities of duplicate sample spots. pp38α, phospho-p38 alpha (T181/Y185); HIF2α, hypoxia inducible factor 2 alpha; ADAMTS1, a disintegrin and metalloproteinase with thrombospondin motifs 1; pp53, phospho-p53 (S46); pHSP-27, phospho heat shock protein-27; Bcl-2, B cell lymphoma-2; PON1, paraoxonase 1; HSP-60, heat shock protein-60; CA IX, carbonic anhydrase IX; PON2, paraoxonase 2; HSP-70, heat shock protein-70; Cited2, Cbp/p300-interacting transactivator; PON3, paraoxonase 3; IDO, indoleamine 2,3-dioxygenase; COX-2, cyclooxygenase-2; Thio-1, thioredoxin-1; pJNK, phospho c-Jun n-terminal kinase (T183/Y185); CytC, cytochrome C; SIRT2, sirtuin 2; NFkB1, nuclear factor kappa B1; Dkk-4, dickkopf-4; SOD2, superoxide dismutase 2; p21/CIP1, cyclin-dependent kinase inhibitor 1A; FABP-1, fatty acid binding protein-1; - Ctr, negative control; p27, cyclin-dependent kinase inhibitor 1B; HIF1α, hypoxia inducible factor 1 alpha; a.u., arbitrary units.